| Financial Year |
March 31 2023 |
| Monetary Funds |
826,606,964.12 |
| Held-for-trading Financial Assets |
139,103,196.48 |
| Notes Receivable |
85,526,192.75 |
| Accounts Receivable |
500,828,623.34 |
| Advances to Suppliers |
157,779,800.07 |
| Other Receivables |
41,877,239.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
630,958,055.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
39,662,806.36 |
| Total Current Assets |
2,516,554,166.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,758,673.90 |
| Investment Properties |
60,117,581.37 |
| Fixed Assetes |
259,643,030.67 |
| Under-construction Projects |
1,411,230.06 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
37,695,923.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,455,338.79 |
| Deferred Income Tax Assets |
4,419,137.19 |
| Other Non-Current Assets |
198,849.56 |
| Sub-Total of Non-Current Assets |
1,244,485,597.93 |
| Total Assets |
3,761,039,764.71 |
| Short-Term Loans |
789,087,863.82 |
| Trading Financial liabilities |
581,926.65 |
| Notes Payable |
387,295,125.70 |
| Accounts Payable |
294,995,410.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,593,295.42 |
| Taxes Payable |
18,256,067.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
64,981,557.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,563,929.18 |
| Other Current Liabilities |
5,581,806.71 |
| Sub-Total of Current Liabilities |
1,688,263,231.77 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
134,357,397.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
137,812,652.97 |
| Total Liabilities |
1,826,075,884.74 |
| Paid-In Capital(Or Share Stock) |
440,923,743.00 |
| Capital Surplus |
209,848,112.24 |
| Surplus Reserve |
214,956,173.52 |
| LESS:Treasury Stock |
11,928,963.41 |
| Undistributed Profits |
516,680,361.48 |
| Minority Stockholder's Interest |
172,959,734.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,762,004,145.22 |
| Owner's Equity（Stockholder's Equity） |
1,934,963,879.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,761,039,764.71 |
